Suppr超能文献

缺血性中风患者静脉注射组织型纤溶酶原激活剂(t-PA)使用情况的差异:基于人群的近期时间趋势

Disparities in the Use of Intravenous t-PA among Ischemic Stroke Patients: Population-based Recent Temporal Trends.

作者信息

Faysel Mohammad A, Singer Jonathan, Cummings Caroline, Stefanov Dimitre G, Levine Steven R

机构信息

Medical Informatics Program, College of Health Related Professions, SUNY Downstate Medical Center, Brooklyn, New York.

Department of Psychology, University of Nevada, Reno, Nevada.

出版信息

J Stroke Cerebrovasc Dis. 2019 May;28(5):1243-1251. doi: 10.1016/j.jstrokecerebrovasdis.2019.01.013. Epub 2019 Feb 8.

Abstract

OBJECTIVE

To explore a 5-year comparison of disparities in intravenous t-PA (IV t-PA) use among acute ischemic stroke (AIS) patients based on race, gender, age, ethnic origin, hospital status, and geographic location.

METHODS

We extracted patients' demographic information and hospital characteristics for 2010 and 2014 from the New York Statewide Planning and Research Cooperative System (SPARCS). We compared disparities in IV t-PA use among AIS patients in 2010 to that in 2014 to estimate temporal trends. Multiple logistic regression was performed to compare disparities based on demographic variables, hospital designation, and geographic location.

RESULTS

Overall, there was approximately a 2% increase in IV t-PA from 2010 to 2014. Blacks were 15% less likely to receive IV t-PA compared to Whites in 2014, but in 2010, there was no difference. Patients aged 62-73 had lower odds of receiving IV t-PA than age group ≤61 in both 2010 and 2014. Designated stroke centers in the Lower New York State region were associated with reduced odds of IV t-PA use in 2010 while those located in the Upper New York State region were associated with increased odds of IV t-PA use in both 2010 and 2014, compared to their respective nondesignated counterparts. Gender, ethnic origin, and insurance status were not associated with IV t-PA utilization in both 2010 and 2014.

CONCLUSION

Overall IV t-PA utilization among AIS patients increased between 2010 and 2014. However, there are evident disparities in IV t-PA use based on patient's race, age, hospital geography, and stroke designation status.

摘要

目的

探讨基于种族、性别、年龄、族裔、医院状况和地理位置的急性缺血性卒中(AIS)患者静脉注射组织型纤溶酶原激活剂(IV t-PA)使用差异的5年比较情况。

方法

我们从纽约全州规划与研究合作系统(SPARCS)中提取了2010年和2014年患者的人口统计学信息及医院特征。我们比较了2010年和2014年AIS患者IV t-PA使用的差异,以估计时间趋势。进行多因素逻辑回归以比较基于人口统计学变量、医院指定类型和地理位置的差异。

结果

总体而言,2010年至2014年IV t-PA的使用量大约增加了2%。2014年,与白人相比,黑人接受IV t-PA的可能性低15%,但在2010年,两者没有差异。在2010年和2014年,62 - 73岁的患者接受IV t-PA的几率均低于61岁及以下年龄组。与各自未指定的对应医院相比,2010年纽约州下部地区指定的卒中中心与IV t-PA使用几率降低相关,而2010年和2014年位于纽约州上部地区的卒中中心与IV t-PA使用几率增加相关。性别、族裔和保险状况在2010年和2014年均与IV t-PA的使用无关。

结论

2010年至2014年期间,AIS患者中IV t-PA的总体使用量有所增加。然而,基于患者种族、年龄、医院地理位置和卒中指定状态,IV t-PA的使用存在明显差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验